CytoDyn Market Cap

CytoDyn has a market cap or net worth of $356.61 million as of July 3, 2025. Its market cap has increased by 157.32% in one year.

Market Cap

356.61M

Enterprise Value

367.52M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.29

Market Cap Chart

Since November 17, 2005, CytoDyn's market cap has increased from 5.54M to 356.61M, an increase of 6,339.77%. That is a compound annual growth rate of 23.63%.

Market Cap History

Date	Market Cap	% Change
Jul 3, 2025	356.61M	164.87%
Dec 31, 2024	134.63M	-29.42%
Dec 29, 2023	190.74M	2.63%
Dec 30, 2022	185.85M	-72.64%
Dec 31, 2021	679.28M	-78.86%
Dec 31, 2020	3.21B	695.20%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.63B
Veradigm	823.67M
Nika Pharmaceuticals	708.22M
Elite Pharmaceuticals	639.84M
Tian'an Technology Group	628.15M
Glass House Brands	557.29M
American Oncology Network	418.01M
Northwest Biotherapeutics	366.72M

Market Cap Rankings